Target intelligence / Profile preview

LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated pseudogene 5 (LSM3P5)

Target: LSM3P5
Molecular classification: Other (Pseudogene)

Overview

LSM3P5 is a human pseudogene (non-functional genomic locus) homologous to the LSM3 gene, which encodes a protein component of the LSM protein complex involved in U6 small nuclear RNA and mRNA degradation. While functional LSM3 is essential for normal RNA decapping, degradation, and splicing in cells, LSM3P5 itself does not encode an active protein and is classified as a processed pseudogene. Pseudogenes like LSM3P5 may occasionally exert indirect regulatory effects via RNA-mediated mechanisms, but there is no direct experimental evidence that LSM3P5 is functional or disease-associated.

Other names: LSM3P5LSM3 pseudogene 5

Mechanism of action

None. No mechanism of action data exists for any drugs or interventions related to LSM3P5.

Biological functions

Pseudogenes generally do not encode functional proteins and thus lack direct biological functions.There is emerging evidence that some pseudogenes may play regulatory roles by acting as RNA decoys for microRNAs or regulators of parental gene expression, but no specific functional data or experimentally validated role is attributed to LSM3P5.

Disease associations

No direct disease associations.Pseudogenes have been implicated broadly in cancer and other diseases via regulatory non-coding RNA mechanisms, but no published evidence specifically assigns LSM3P5 a role in disease.

Safety considerations

None. There are no safety concerns or therapeutic challenges because the pseudogene has no known function in therapy.

Beyond the preview

Go deeper on LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated pseudogene 5 (LSM3P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated pseudogene 5 (LSM3P5).

Explore the full profile